When it comes to cancer care, DNA tumor testing is vital to providing individualized treatment. Mayo Clinic Laboratories’ liquid biopsy is a noninvasive alternative to traditional cell-based biopsies. Liquid biopsies allow for faster turnaround time and the ability to perform molecular testing in patients where tumor tissue isn’t available.

The MayoComplete Liquid Biopsy Panel (Mayo ID: MCLBP) detects single nucleotide variants, insertions, and deletions in 33 target genes and assesses gene amplifications, translocations, and microsatellite instability.

For more information, listen to this “Test in Focus” podcast episode on Mayo Clinic Laboratories Insights.